Literature DB >> 27765168

Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy.

Lucas Goense1, Peter S N van Rossum1, Jelle P Ruurda2, Marco van Vulpen3, Stella Mook3, Gert J Meijer3, Richard van Hillegersberg4.   

Abstract

BACKGROUND: Concerns have been raised regarding the toxicity of neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer that could contribute to an increased risk of postoperative complications. The aim of this study was to determine the influence of the radiation dose to the gastric fundus on the risk of postoperative anastomotic leakage in patients undergoing nCRT followed by transthoracic esophagectomy.
METHODS: Between January 2012 and July 2015, 97 consecutive patients who underwent nCRT followed by transthoracic esophagectomy were included in this single-center cohort study. The gastric fundus was contoured on the pretreatment planning computed tomography. Within this contour, dose-volume histogram variables were calculated, and logistic regression analysis was used to determine their influence on the risk of anastomotic leakage.
RESULTS: In 25 of 97 patients (26%) anastomotic leakage occurred. The mean radiation dose to the gastric fundus was significantly higher in patients with than without leakage (median 35.6 Gy versus 24.9 Gy, respectively, p = 0.047). A mean dose more than versus less than 31.4 Gy was associated with leakage rates of 43% versus 15%, respectively. Adjusted for tumor location, clinical T stage, and radiation method, the mean radiation dose to the gastric fundus remained significantly and independently associated with an increased risk of anastomotic leakage (adjusted odds ratio 1.05 per 1-Gy increase, 95% confidence interval: 1.002 to 1.10, p = 0.043).
CONCLUSIONS: Efforts should be made to minimize the radiation dose to the gastric fundus when planning nCRT for esophageal cancer, because higher dose levels to the gastric fundus are associated with an increased risk of anastomotic leakage after subsequent transthoracic esophagectomy and cervical anastomosis.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27765168     DOI: 10.1016/j.athoracsur.2016.08.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

Review 1.  Minimally invasive esophagectomy for Barrett's adenocarcinoma.

Authors:  Emanuele Asti; Daniele Bernardi; Marco Sozzi; Luigi Bonavina
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-16

Review 2.  Hybrid and total minimally invasive esophagectomy: how I do it.

Authors:  Luigi Bonavina; Emanuele Asti; Andrea Sironi; Daniele Bernardi; Alberto Aiolfi
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  Gastro-esophageal junction cancers: what is the best minimally invasive approach?

Authors:  Egle Jezerskyte; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Peripheral blood inflammation indices are effective predictors of anastomotic leakage in elective esophageal surgery.

Authors:  Cai-Xia Wu; Ding-Yu Rao; Cheng-Peng Sang; Shen-Yu Zhu; Liang Gu; Yan-Yang Wu; Jian-Feng Wang; Hua-Qiu Shi; Xiang-Cai Wang; Zhi-Xian Tang
Journal:  J Gastrointest Oncol       Date:  2021-12

5.  Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA).

Authors: 
Journal:  BJS Open       Date:  2021-05-07

6.  Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA).

Authors: 
Journal:  BJS Open       Date:  2021-05-07

7.  Development and validation of a nomogram to predict anastomotic leakage after esophagectomy for esophageal carcinoma.

Authors:  Wen-Quan Yu; Hui-Jiang Gao; Guo-Dong Shi; Jia-Yu Tang; Hua-Feng Wang; Shi-Yu Hu; Yu-Cheng Wei
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

8.  A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage at the anastomotic site after esophagectomy.

Authors:  Mitsuro Kanda; Masahiko Koike; Masahide Fukaya; Kazushi Miyata; Chie Tanaka; Daisuke Kobayashi; Masamichi Hayashi; Suguru Yamada; Goro Nakayama; Kenta Murotani; Michitaka Fujiwara; Masato Nagino; Yasuhiro Kodera
Journal:  Nagoya J Med Sci       Date:  2020-02       Impact factor: 1.131

Review 9.  Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment.

Authors:  M Fabbi; E R C Hagens; M I van Berge Henegouwen; S S Gisbertz
Journal:  Dis Esophagus       Date:  2021-01-11       Impact factor: 3.429

10.  Does Radiation Dose to Gastric Fundus during Neoadjuvant Chemoradiotherapy for Esophageal Carcinoma Have an Impact on Postoperative Anastomotic Leak?

Authors:  Nikhila Radhakrishna; Shyama Prem Sudha; Raja Kalayarasan; Prasanth Penumadu
Journal:  Gastrointest Tumors       Date:  2021-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.